10% w/v DEXTROSE & 0.225% w/v SODIUM CHLORIDE INJECTION USP Infusion
Dextrose 10% + Sodium Chloride 0.225%
"100mg, 2.25mg/ml"
Qatar Pharma
| Pack size | 1000ml Plastic Bag |
|---|---|
| Dispensing mode | POM |
| Source | QATAR |
| Agent | PHARMAWORLD |
| Retail Price | 6.50 AED |
Available as:
Indications
10% w/v DEXTROSE & 0.225% w/v SODIUM CHLORIDE INJECTION USP Infusion is used for:
Dehydration, Fluid and Electrolytes imbalance
Adult Dose
The dose is dependent upon the age, weight and clinical condition of the patient.
As reported in the literature, the dosage and constant infusion rate of intravenous dextrose must be selected with caution in pediatric patients, particularly neonates and low birth weight infants, because of the increased risk of hyperglycemia/hypoglycemia.
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.
Child Dose
The dose is dependent upon the age, weight and clinical condition of the patient.
As reported in the literature, the dosage and constant infusion rate of intravenous dextrose must be selected with caution in pediatric patients, particularly neonates and low birth weight infants, because of the increased risk of hyperglycemia/hypoglycemia.
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.
Renal Dose
Administration
Contra Indications
Hypersensitivity.
Precautions
Clinical evaluation and periodic laboratory determinations are necessary to monitor changes in fluid balance, electrolyte concentrations and acid-base balance during prolonged parenteral therapy or whenever the condition of the patient warrants such evaluation.
Solutions containing dextrose should be used with caution in patients with known subclinical or overt diabetes mellitus.
Caution must be exercised in the administration of parenteral fluids, especially those containing sodium ions to patients receiving corticosteroids or corticotropin.
Do not administer unless solution is clear and container is undamaged. Discard unused portion.
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Dextrose 10% + Sodium Chloride 0.225% :
Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation and hypervolemia.
If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures and save the remainder of the fluid for examination if deemed necessary.
Mechanism of Action
Dextrose and sodium chloride solutions are used as sources of electrolytes, calories and water for hydration. Sodium and chloride ions are responsible for regulating the acid-base balance of the body. Dextrose is a source of calories. It is readily metabolised and helps to decrease losses of body protein and nitrogen. It also promotes glycogen deposition and decreases or prevents ketosis.
Note
10% w/v DEXTROSE & 0.225% w/v SODIUM CHLORIDE INJECTION USP "100mg, 2.25mg/ml" Infusion manufactured by Qatar Pharma. Its generic name is Dextrose 10% + Sodium Chloride 0.225%. 10% w/v DEXTROSE & 0.225% w/v SODIUM CHLORIDE INJECTION USP is availble in United Arab Emirates.
Farmaco UAE drug index information on 10% w/v DEXTROSE & 0.225% w/v SODIUM CHLORIDE INJECTION USP Infusion is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.
Some other brands of Dextrose 10% + Sodium Chloride 0.225% :
Infusion
10% w/v DEXTROSE & 0.225% w/v SODIUM CHLORIDE INJECTION USP
"100mg, 2.25mg/ml"
Qatar Pharma
Infusion
10% w/v DEXTROSE & 0.225% w/v SODIUM CHLORIDE INJECTION USP
"100mg, 2.25mg/ml"
Qatar Pharma
Infusion
10% w/v DEXTROSE & 0.225% w/v SODIUM CHLORIDE INJECTION USP
"100mg, 2.25mg/ml"
Qatar Pharma